Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acne Vulgaris
Coria Laboratories Announces Acanya(TM) Gel Data Presentations at 67th American Academy of Dermatology Annual Meeting
March 13th, 2009
Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals International (NYSE:VRX), announced six data presentations on Acanya Gel at the 67th Annual Meeting of the American Academy of Dermatology (AAD), taking place March 6 - 10, 2009, at the Moscone Center, San Francisco. The presentations demonstrate the efficacy and safety of once daily Acanya Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) in treating patients with moderate to severe acne vulgaris. "Data to be presented at AAD will confirm the superior efficacy of Acanya Gel over active ingredients and vehicle for both inflammatory and non-inflammatory acne lesions, while...
Source: Health Business Week (2009-03-13)
|
